Redsense Medical

Patrik Byhmer was the founder of the company and Chairman of the Board since August 2022 when he resigned as CEO. Patrik was instrumental in the development of the company and in establishing a disruptive and lifesaving technology for the dialysis market. The Board of Directors will appoint a Chairman of the Board among its current members until a new Chairman of the Board has been elected by the Annual General Meeting.

Pontus Nobréus, CEO of Redsense Medical comments: "Patrik will always be remembered as a warm, visionary and entrepreneurial leader with a strong sense of business acumen to bring new innovative products to the market".

Our thoughts and heartfelt condolences are extended to Patriks's family and loved ones during this difficult period.

This information is information that Redsense Medical AB is obliged to make public pursuant to the EU Market Abuse Regulation (MAR). The information was submitted for publication, through the agency of the contact person set out below, on December 23, 2023.